Identity
- Trade Name
- Spectrum Laser/IPL FDA UDI
- Generic Name
- Multi-modality skin surface treatment system generator FDA UDI
- Model / Reference
- Spectrum FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00860564000317 FDA UDI
- FDA Product Code
- ONE FDA UDI
- GMDN Term
- Multi-modality skin surface treatment system generator FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 878.4810 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Multi-modality skin surface treatment system generator
Spectrum Laser/IPL by Rohrer Aesthetics, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Multi-modality skin surface treatment system generator.
- Nordlys System — Candela Corporation · Class II
- MCL 31 Dermablate — Asclepion Laser Technologies GmbH · Class II
- TheraClear — Theravant Corporation · Class II
- Frax Pro — Candela Corporation · Class II
- Applicator Frax 1550 1550 nm — Candela Corporation · Class II
- V30 Console — VIORA LTD · Class II
- ASSY, 1540 HANDPIECE, ICON — Cynosure, LLC · Class II
- Aerolase — Aerolase Corporation · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Rohrer Aesthetics, Inc.
Sources (1)
- FDA UDI 3ef2f223-4827-44c6-ad4a-912b358b17de 32 fields · synced May 30, 2026